Back to Search
VIJAY MANNE, M.D.
M.D.
Pediatrics Physician
NPI: 1265850440Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
4301500780(MI)
Hospitalist Physician
Hospitalist
Code: 208M00000X
145445(CA)
Research & Publications (13)
Apoptotic and cytostatic farnesyltransferase inhibitors have distinct pharmacology and efficacy profiles in tumor models.
PMID 15173010·Cancer Res·2004
7-preclinical
Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily.
PMID 19260711·J Med Chem·2009
7-preclinical
Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological activities.
PMID 18690676·J Med Chem·2008
7-preclinical
Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors.
PMID 18479916·Bioorg Med Chem Lett·2008
7-preclinical
Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinase.
PMID 18289854·Bioorg Med Chem Lett·2008
7-preclinical
Chemical genetics identifies Rab geranylgeranyl transferase as an apoptotic target of farnesyl transferase inhibitors.
PMID 15837622·Cancer Cell·2005
7-preclinical
Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors.
PMID 15780629·Bioorg Med Chem Lett·2005
7-preclinical
Phase I pharmacokinetic and pharmacodynamic study of weekly 1-hour and 24-hour infusion BMS-214662, a farnesyltransferase inhibitor, in patients with advanced solid tumors.
PMID 15710949·J Clin Oncol·2005
3-trial
Preclinical antitumor activity of BMS-214662, a highly apoptotic and novel farnesyltransferase inhibitor.
PMID 11606387·Cancer Res·2001
7-preclinical
Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity.
PMID 11020273·J Med Chem·2000
7-preclinical
3-Imidazolylmethylaminophenylsulfonyltetrahydroquinolines, a novel series of farnesyltransferase inhibitors.
PMID 10698452·Bioorg Med Chem Lett·2000
8-other
Contribution of Ras GTPase/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt-induced hypertension.
PMID 10642341·Hypertension·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 8 locations total
- Address
- 400 HOBART ST
CADILLAC, MI 49601 - Phone
- (231) 876-7200
Locations (8)
Practice Location
400 HOBART ST, CADILLAC, MI
(231) 876-7200
Practice Location
14700 Lake Shore Dr, Charlevoix, MI
(231) 547-3840
Practice Location
3901 BEAUBIEN ST, DETROIT, MI
(313) 966-0128
Practice Location
829 N CENTER AVE STE 130, GAYLORD, MI
(989) 731-7930
Practice Location
825 N CENTER AVE, GAYLORD, MI
(989) 731-7996
Practice Location
1250 E Michigan Ave Ste C, Grayling, MI
(989) 348-0550
Practice Location
1100 E MICHIGAN AVE, GRAYLING, MI
(989) 348-5461
Practice Location
825 Delbon Ave, Turlock, CA
(209) 664-2899
Quick Facts
- NPI
- 1265850440
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 8
- Publications
- 13
Are you this provider?
Claim Your Profile